Avai BioAVAI -3.77%24 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 2,816 Software companies, Avai Bio ranks worse than 35511.33% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Avai Bio's EBITDA for the
three
months ended in Dec. 2025 was $-0.55 Mil. Avai Bio's Revenue for the
three
months ended in Dec. 2025 was $0.00 Mil. Therefore, Avai Bio's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
Avai Bio (OTCPK:AVAI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Avai Bio EBITDA Margin % Related Terms
Avai Bio EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Avai Bio's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVAI vs IPM, RCT, LPSN: EBITDA Margin % Comparison
For the Software - Application subindustry, Avai Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avai Bio EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Avai Bio's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Avai Bio's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avai Bio (AVAI) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #999999 out of 2816 companies in the Software industry.
Is Avai Bio's EBITDA Margin % too high?
Avai Bio's current EBITDA Margin % is 0.00%. Based on the distribution chart, Avai Bio ranks #999999 out of 2816 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's EBITDA Margin % compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #999999 out of 2816 companies for EBITDA Margin %. This places Avai Bio in the lower half of its industry. The industry median EBITDA Margin % is 7.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 7.99, based on 2,816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Avai Bio and its competitors. For the Software industry, the median EBITDA Margin % is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Avai Bio (AVAI), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score
Get the complete analysis for AVAI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAI has been successfully added to your 
